PERITONEAL MESOTHELIOMA MALIGNANT

PERITONEAL MESOTHELIOMA MALIGNANT was reported 193 times

These drug classes are most commonly taken by patients reporting PERITONEAL MESOTHELIOMA MALIGNANT:

# Drug Count
0 Platinum-based Drug [EPC] 7
1 Folate Analog Metabolic Inhibitor [EPC] 5
2 Nucleoside Metabolic Inhibitor [EPC] 5
3 Corticosteroid [EPC] 4
4 Vitamin B12 [EPC] 4
5 Vitamin C [EPC] 4
6 Vitamin D [EPC] 4
7 Amide Local Anesthetic [EPC] 3
8 Antiarrhythmic [EPC] 3
9 Nonsteroidal Anti-inflammatory Drug [EPC] 3
10 Proton Pump Inhibitor [EPC] 3
11 Antidote [EPC] 2
12 Atypical Antipsychotic [EPC] 2
13 Benzodiazepine [EPC] 2
14 CD20-directed Cytolytic Antibody [EPC] 2
15 Kinase Inhibitor [EPC] 2
16 Loop Diuretic [EPC] 2
17 Microtubule Inhibitor [EPC] 2
18 Tumor Necrosis Factor Blocker [EPC] 2
19 Vascular Endothelial Growth Factor Inhibitor [EPC] 2
20 Alkaloid [EPC] 1
21 Alkylating Drug [EPC] 1
22 Barbiturate [EPC] 1
23 Central Nervous System Stimulant [EPC] 1
24 Cholinergic Nicotinic Agonist [EPC] 1
25 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
26 Expectorant [EPC] 1
27 Factor Xa Inhibitor [EPC] 1
28 GLP-2 Analog [EPC] 1
29 HMG-CoA Reductase Inhibitor [EPC] 1
30 Interleukin-12 Antagonist [EPC] 1
31 Interleukin-23 Antagonist [EPC] 1
32 Interleukin-6 Receptor Antagonist [EPC] 1
33 Janus Kinase Inhibitor [EPC] 1
34 Methylxanthine [EPC] 1
35 Non-Standardized Food Allergenic Extract [EPC] 1
36 Non-Standardized Plant Allergenic Extract [EPC] 1
37 Opioid Agonist [EPC] 1
38 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
39 Proteasome Inhibitor [EPC] 1
40 RANK Ligand Inhibitor [EPC] 1
41 Recombinant Human Growth Hormone [EPC] 1
42 Serotonin-3 Receptor Antagonist [EPC] 1
43 Thalidomide Analog [EPC] 1
44 Thiazide Diuretic [EPC] 1
45 Topoisomerase Inhibitor [EPC] 1
46 Xanthine Oxidase Inhibitor [EPC] 1
47 mTOR Inhibitor Immunosuppressant [EPC] 1